These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 34513446)

  • 1. Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female.
    Jasaraj RB; Shrestha DB; Gaire S; Kassem M
    Cureus; 2021 Aug; 13(8):e16871. PubMed ID: 34513446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine.
    Malayala SV; Papudesi BN; Sharma R; Vusqa UT; Raza A
    Cureus; 2021 Oct; 13(10):e18985. PubMed ID: 34820240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
    Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young Woman.
    Fujita M; Ureshino H; Sugihara A; Nishioka A; Kimura S
    Cureus; 2021 Sep; 13(9):e17942. PubMed ID: 34660131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccination associated severe immune thrombocytopenia.
    Shah SRA; Dolkar S; Mathew J; Vishnu P
    Exp Hematol Oncol; 2021 Jul; 10(1):42. PubMed ID: 34266487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine.
    Aharoni M; Leader A; Shochat T; Raanani P; Spectre G
    Platelets; 2022 Jul; 33(5):781-786. PubMed ID: 35536172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
    Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Successfully Treated COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura.
    Rodriguez Guerra MA; Chinta S; Urena Neme AP; Gupta S; Roa Gomez G
    Cureus; 2023 Dec; 15(12):e49878. PubMed ID: 38174163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP.
    Jawed M; Khalid A; Rubin M; Shafiq R; Cemalovic N
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab343. PubMed ID: 34307734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Multiple Myeloma: Case Report and Literature Review.
    Dan C; Sahai A; Dan D; Sahai A; Trehan R
    Cureus; 2023 Oct; 15(10):e46784. PubMed ID: 37954740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.
    Baba Y; Sakai H; Kabasawa N; Harada H
    Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Al-Maqbali JS; Al Rasbi S; Kashoub MS; Al Hinaai AM; Farhan H; Al Rawahi B; Al Alawi AM
    Am J Case Rep; 2021 Jun; 22():e932946. PubMed ID: 34117206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Thrombocytopenic Purpura following Administration of mRNA-Based SARS-CoV-2 and MMR Vaccinations: A Cautionary Tale.
    Thomas W; Albano A; Kirkel D; Rouhizad N; Arinze F
    Case Rep Infect Dis; 2021; 2021():2704249. PubMed ID: 34635874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Onset Severe Immune Thrombocytopenia following mRNA COVID-19 Vaccine in a Young Patient.
    Avila J; Degirmenci HB; Contreras Chavez P; Battinelli EM; Fleisher J
    Case Rep Hematol; 2023; 2023():7877536. PubMed ID: 36950529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine.
    Pavenski K
    TH Open; 2021 Jul; 5(3):e335-e337. PubMed ID: 34568744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-induced immune thrombocytopenia management approach: A case report and literature review.
    Alahwal HM; Alsharif MH; Alsharif MH; Almohammadi AT; Al-Marzouki AF; Barefah AS; Bahashwan SM; Radhwi OO; Damanhouri GA
    Clin Case Rep; 2024 Jun; 12(6):e9070. PubMed ID: 38883219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.
    Saudagar V; Patil S; Goh S; Pothiawala S
    Ir J Med Sci; 2022 Apr; 191(2):919-920. PubMed ID: 33788135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.